Authors: Begueret, H Trouette, H Vielh, P Laurent, C MacGrogan, G Delsol, M Belleannee, G Masson, B De Mascarel, A

Citation: H. Begueret et al., Hepatic undifferentiated embryonal sarcoma: malignant evolution of mesenchymal hamartoma? Study of one case with immunohistochemical and flow cytometric emphasis, J HEPATOL, 34(1), 2001, pp. 178-179

Authors: Coindre, JM Blanc-Vincent, MP Collin, F MacGrogan, G Balaton, A Voigt, JJ

Citation: Jm. Coindre et al., Standards, Options and Recommendations: practice guidelines for difficult diagnosis in surgical pathology or cytopathology in cancer patients, B CANCER, 88(8), 2001, pp. 765-773

Authors: de Mascarel, I Bonichon, F MacGrogan, G de Lara, CT Avril, A Picot, V Durand, M Mauriac, L Trojani, M Coindre, JM

Citation: I. De Mascarel et al., Application of the Van Nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examinated by serial macroscopic sectioning: Practical considerations, BREAST CANC, 61(2), 2000, pp. 151-159

Authors: Mauriac, L MacGrogan, G Avril, A Durand, M Floquet, A Debled, M Dilhuydy, JM Bonichon, F

Citation: L. Mauriac et al., Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: Aunicentre randomized trial with a 124-month median follow-up, ANN ONCOL, 10(1), 1999, pp. 47-52

Authors: Rudolph, P MacGrogan, G Bonichon, F Frahm, SO de Mascarel, I Trojani, M Durand, M Avril, A Coindre, JM Parwaresch, R

Citation: P. Rudolph et al., Prognostic significance of Ki-67 and topoisomerase II alpha expression in infiltrating ductal carcinoma of the breast - A multivariate analysis of 863 cases, BREAST CANC, 55(1), 1999, pp. 61-71